Abiopharma

🔍 Hoxworth Seth Alan (Executive)

Company: CITIZENS, INC. (CIA)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Holds 0 shares of Citizens, Inc. Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 5,351.66
• Acquired 4,572 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,572.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 5,964 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,964.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Holds 5,401 shares of Citizens, Inc. Class A Common Stock (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 5,401.00 | Footnotes: F4, F1, F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock.
• F2: On March 31, 2026, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2025 pay-for-performance. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2027) an dthe second anniversary of the date of the grant (March 31, 2028) and the third anniversary of the date of the grant (March 31, 2029).
• F3: On March 31, 2026, the reporting person was granted an award of RSUs under the Citizens, Inc. Omnibus Incentive Plan for the 2026 long-term incentive. The RSUs vest in three equal annual installments on the first anniversary of the date of the grant (March 31, 2027) an dthe second anniversary of the date of the grant (March 31, 2028) and the third anniversary of the date of the grant (March 31, 2029).
• F4: Initial grant was issued January 6, 2025 and remaining shares will vest 1/2 on January 6, 2027 and 1/2 on January 6, 2028.